doi: 10.1016/j.imbio.2012.11.002 149 JafariMAhangariGSaberiMSamangouiSTorabiRZoualiM
[4] Pharmacokinetics and Distribution Pharmacokinetic work in mice reported systemic exposure and distribution of 5-Amino-1MQ to metabolically active tissues, including adipose, muscle, and liver, after subcutaneous compound application
When to seek medical advice: Persistent injection site reactions lasting more than one week Signs of infection (increasing warmth, spreading redness, purulent discharge, fever) Severe pain or swelling at the injection site Signs of severe allergic reaction (widespread rash, difficulty breathing, facial swelling) seek urgent medical attention or call 999 Unexplained lumps or significant changes in subcutaneous tissue Patients experiencing recurrent or troublesome injection site problems should consult their GP or diabetes specialist nurse, who may recommend alternative injection sites, review technique, or consider whether the reactions represent a hypersensitivity to the medication
That makes this option less forgiving than many people expect
In subjects with T2D, LY3298176 reduced fasting glucose, glucose excursions and body weight with increasing doses
Clinical Assessment: A thorough medical history and a detailed discussion of symptoms are key components of diagnosis
